SC 13G
SCHEDULE 13G
- Company
- Mereo BioPharma Group plc
- Filed
- February 12, 2021
- Accession Number
- 0000947871-21-000180
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →